Filing Details
- Accession Number:
- 0001038133-16-000279
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-07-11 16:44:14
- Reporting Period:
- 2016-07-01
- Filing Date:
- 2016-07-11
- Accepted Time:
- 2016-07-11 16:44:14
- Original Submission Date:
- 2016-07-01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1038133 | Heska Corp | HSKA | Biological Products, (No Disgnostic Substances) (2836) | 770192527 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1570492 | S. Kevin Wilson | 3760 Rocky Mountain Avenue Loveland CO 80538 | Ceo And President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-07-01 | 14,040 | $38.94 | 165,960 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 124,099 | Indirect | by Cuattro, LLC |
Common Stock | 13,432 | Indirect | by Daughter |
Common Stock | 13,432 | Indirect | by Son |
Common Stock | 13,432 | Indirect | by Son II |
Common Stock | 13,432 | Indirect | by Son III |
Common Stock | 20,092 | Indirect | by Spouse |
Common Stock | 138,743 | Indirect | by Wilson Family Tr. |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 3, 2016.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.95 to $40.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commision, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.